相关实验视频
Updated: Jul 26, 2025
09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
17.7K
GLUT9作为慢性病的潜在药物标:通过孟德尔随机化研究对药物标的验证
Masatoshi Ueda1, Kenji Fukui2, Naoyuki Kamatani3
1Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan. masatoshi.ueda@jt.com.
Journal of human genetics
|June 12, 2023
概括
慢性病 (CKD) 影响公众健康,治疗方法有限. 向尿酸载体SLC2A9可能通过降低血清尿酸水平来保持功能,提供一种新的治疗策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 是一个重要的全球健康问题,治疗需求尚未得到满足.
- 尿酸 (UA) 是痛风和潜在的CKD的危险因素,但CKD的UA降低治疗的有效性仍在争论中.
- 确定有效的药物点对于开发新的CKD疗法至关重要.
研究的目的:
- 调查血清尿酸水平与功能 (eGFR) 之间的因果关系.
- 评估特定的尿酸载体作为CKD的潜在治疗点.
- 评估SLC2A9在尿酸和功能之间的关联中的作用.
主要方法:
- 使用单个SNP孟德尔随机化分析.
- 专注于五个关键的尿酸输送体:ABCG2,SLC17A1,SLC22A11,SLC22A12和SLC2A9.9. 这五个主要的尿酸输送体是:ABCG2,SLC17A1,SLC22A11,SLC22A12和SLC2A9.
- 研究了基因预测的血清UA水平和eGFR之间的关联,特别是使用SLC2A9位点的变异.
主要成果:
- 在基因影响的血清UA水平和估计的淋巴细胞过率 (eGFR) 之间确定了因果关系.
- 在SLC2A9基因位点内的遗传变异表明了这种关联.
- 在SLC2A9 (rs16890979) 中的功能丧失突变表明,增加的血清UA水平因果性地减少了eGFR -0.0082毫升/分钟/1.73米2.
结论:
- 尿酸载体SLC2A9是CKD的一个潜在的新药标.
- 向SLC2A9可以通过尿酸降低效应来保持功能.
- 对SLC2A9调制的进一步研究可能会导致有效的CKD治疗方法.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
43
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
43
01:28Chronic Kidney Disease III: Interprofessional Care
50
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
50
01:24Chronic Kidney Disease II: Clinical Manifestations
42
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
42
01:02Renal Drug Excretion: Glomerular Filtration
340
The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production occurs. A nephron has two main components: a renal corpuscle and a renal tubule.
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....
340